Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease and Osler-Weber-Rendu syndrome, is a genetic disorder that leads to abnormal blood vessel formation in the skin, mucous membranes, and often in organs such as the lungs, liver and brain.
It may lead to nosebleeds, acute and chronic digestive tract bleeding, and various problems due to the involvement of other organs. Treatment focuses on reducing bleeding from blood vessel lesions, and sometimes surgery or other targeted interventions to remove arteriovenous malformations in organs. Chronic bleeding often requires iron supplements and sometimes blood transfusions. HHT is transmitted in an autosomal dominant fashion, and occurs in one in 5,000 people.
Other articles related to "hereditary hemorrhagic telangiectasia, hereditary":
... common features of HHT, particularly the recurrent nosebleeds and the hereditary nature of the disease ... The term "hereditary hemorrhagic telangiectasia" was first used by the American physician Frederic M ...
Famous quotes containing the word hereditary:
“We bring [to government] no hereditary status or gift of infallibility and none follows us from this place.”
—Gerald R. Ford (b. 1913)